In Baton Rouge, where schoolchildren are learning the long-standing lessons of healthy eating and movement, a physician now reports a newer chapter in how childhood weight is treated: some young patients are receiving GLP-1 medications, drugs first embraced by adults, after the familiar advice has run its course. The account comes from one doctor's experience, not from published prescribing records, and it reminds us that a society's campaign for healthier children unfolds alongside private decisions made in clinics, where biology, cost, and hope must be weighed together.
Some Children Now Receive GLP-1 Weight-Loss Drugs, Physician Says, as Cost Limits Access
"It's not a miracle drug — it's a tool."
Mark
So what is actually new here?
Mimi
Dr. Rogers says GLP-1 drugs, familiar from adult weight loss, are now being prescribed to some children when lifestyle changes haven't worked.
Mark
Why would diet and exercise fail?
Mimi
She points to genetics and a hormonal dysregulation that can develop when weight gets very high. She says move more, eat less isn't always enough.
Luke
Worth flagging that this is one physician's account. There are no prescribing numbers, no named patients, no mention of side effects.
Mark
What are the criteria she cites?
Mimi
Experts say the ideal candidate is at or above the 95th BMI percentile with lifestyle changes alone having failed. For diabetes patients, treatment can start at 10 and up.
Luke
Note those are two different things. The age 10 figure is about diabetes, not weight loss. The report doesn't state an age floor for obesity treatment.
Mark
She also says the drugs quiet food noise and are anti-inflammatory.
Luke
Those are her characterizations. The report offers no study behind them.
Mimi
She does add that it's a tool, not a miracle drug, and the whole situation has to be treated.
Mark
And access?
Mimi
Cost is a barrier for many families. Without the drug, the option is balanced meals and a healthy lifestyle.
Luke
Which leaves open how many children actually get these drugs. The report doesn't say.
Der Puls
- A Baton Rouge physician reports that GLP-1 weight-loss drugs are being prescribed to some children whose diet and exercise efforts have stalled.
- The shift unsettles a familiar story of simple willpower, as genetics and hormonal disruption are cited as reasons lifestyle advice sometimes fails.
- Clinicians are working within narrow markers, with ideal candidates at or above the 95th BMI percentile and diabetes patients eligible from age 10.
- Cost stands as the sharpest obstacle, leaving many families without access and returning them to balanced meals and active routines.
- The trajectory hinges on whether clearer pediatric guidelines emerge and whether affordability opens or closes the door for those who need it.
In Baton Rouge, where schoolchildren are learning the long-standing lessons of healthy eating and movement, a physician now reports a newer chapter in how childhood weight is treated: some young patients are receiving GLP-1 medications, drugs first embraced by adults, after the familiar advice has run its course. The account comes from one doctor's experience, not from published prescribing records, and it reminds us that a society's campaign for healthier children unfolds alongside private decisions made in clinics, where biology, cost, and hope must be weighed together.
At Magnolia Woods Elementary in Baton Rouge, Louisiana, students are learning about healthy eating and exercise as part of a statewide push against obesity. Alongside those lessons sits a quieter change: GLP-1 drugs, popular among adults for weight loss, are now being prescribed to some children.
The account comes from Dr. Rhea Rogers, a board-certified physician and host of Aging Untold. Her report rests on her own experience and does not cite prescribing data or name any patients. She argues that for some children, eating better and moving more is not enough, pointing to genetics and a hormonal dysregulation that can take hold when weight climbs high.
Rogers describes the medications as helpful for quieting what she calls food noise, and says they are anti-inflammatory. She is careful, though, not to oversell them. They are a tool, not a miracle, and the whole picture of a child's health must be addressed alongside any prescription.
Eligibility markers include a body mass index at or above the 95th percentile after lifestyle changes have failed, and an age of 10 or older for diabetes patients. Cost remains the practical barrier. Families who cannot afford the drugs, or who choose not to use them, are left with the same balanced meals and healthy habits being taught in classrooms. Whether clearer guidelines arrive, and whether price keeps the medication out of reach for those who might most need it, remains to be seen.
At Magnolia Woods Elementary in Baton Rouge, Louisiana, students are being taught about healthy eating and exercise. The lessons are part of a statewide effort to bring down obesity rates, and they sit alongside a quieter development in the way some children's weight is treated: GLP-1 drugs, the weight-loss medications that have become popular among adults, are now being prescribed to some kids.
That is the account of Dr. Rhea Rogers, a board-certified physician and the host of Aging Untold, who described the shift in a report distributed from Baton Rouge. The report rests on her account alone, and it does not cite prescribing data or name any patients.
Rogers's argument starts from the limits of the usual advice. For some children, she said, eating better and moving more is not enough. She pointed to genetics, and to what she called a hormonal dysregulation that can set in when a child's weight climbs high. In her words, the familiar instruction to move more and eat less sometimes fails because of those underlying factors.
She described the drugs, which she called GLP-1 agonists, as very helpful for quieting what she termed food noise and food chatter. She also said they are anti-inflammatory. Some people, she said, simply need extra help because of the hormonal problem.
On who might qualify, the report gives a few markers. For patients with diabetes, the age requirement can be 10 and up. For weight loss specifically, experts say the ideal candidate has a body mass index at or above the 95th percentile and has not succeeded with lifestyle changes alone. That group includes patients who have developed hormone problems that call for medical intervention.
Rogers was careful not to oversell the medication. It is not a miracle drug, she said, but a tool, and the whole picture has to be treated, not just the prescription.
The practical obstacle is money. The price of GLP-1s remains a barrier for many families. For children whose families cannot afford the medication, or who choose not to use any, the option for now is well-balanced meals and a healthy lifestyle, the same approach being taught in Louisiana classrooms.
What to watch is whether clearer guidelines emerge for prescribing these drugs to children, and whether cost keeps them out of reach for the families who might most want them.
Bemerkenswerte Zitate
It's not a miracle drug — it's a tool, and so you have to treat the whole entire scenario.— Dr. Rhea Rogers, board-certified physician and Aging Untold host
Möchten Sie die ganze Geschichte?
Das Original lesen bei WEAU ↗
Health & Medicine